OLMESARTAN 20mg. IP + HYDROCHLOROTHIAZIDE 12.5mg. IP

A medication is used in the management of hypertension. (Kerndt & Soos.) An effective, fast-acting, and well-tolerated antihypertensive agent. (Brunner, 2006) A well-tolerated and efficient drug in subjects with mild-to-moderate hypertension. (Michael Böhm, 2006) An effective and well-tolerated treatment options in patients who show an inadequate response to low-dose monotherapy with olmesartan medoxomil. (Vivencio Barrios, 2007) An efficacious antihypertensive therapy that results in significant BP reductions and BP control in many patients. (Greathouse, 2006) Reduces systolic BP and diastolic BP to a greater extent than either component as monotherapy. (Greathouse, 2006) Exhibits a potent and long-lasting antihypertensive action without inducing tachycardia. (Toshio Sada, 2004) Represents a useful option among first-line drug treatments of hypertension. (Jean-Michel Mallion, 2011) A valid therapeutic choice for the treatment of hypertension and other cardiovascular and renal diseases. (Jürg Nussberger, 2004) Provides better antihypertensive efficacy than losartan and valsartan. (Long Wang, 2012) A beneficial antihypertensive agent especially for high-risk patients. (Stefano Omboni M. V., 2019) A valuable option for the treatment of essential hypertension in adult patients. (Rajiv Rana, 2010)